Wotld Trade Organization (WTO) celebrated its 20the anniversary and hosted a public forum in Geneva, Switzerland.

Like Comment

Wotld Trade Organization (WTO) celebrated its 20the anniversary and hosted a public forum in Geneva, Switzerland.

The Forum includes some topics related to medicinal chemistry, e.g.:
Working session 10: Principles to Foster Trade in Generic and Biosimilar Medicines

Go to the profile of Takeshi S. Komatani

Takeshi S. Komatani

Patent Attorney, Ph.D., SHUSAKU·YAMAMOTO

Takeshi S Komatani received his PhD from the University of Tokyo, Tokyo, Japan with Professor Kinoue, and registered as Japanese licensed pharmacist. He was a researcher at F. Hoffmann-La Rochein Basel, Switzerland. Thereafter, he joined SHUSAKU·YAMAMOTO, a patent and law firm in Osaka, Japan in 1998, and was registered to practice before the Japanese Patent Office and appear as Paten tand Trademark Counsel before the Japanese Courts, admitted, 2000 and was registered as IP litigation certified intellectual property attorney in 2004. He is currently the Firm's principal of the Chemical/Pharma and Bio/LifeSciences Groups. He is a member of the Association Internationale pour laProtection de la Propriété Industrielle (AIPPI), Standing Committee Q94 regarding TRIPS, and also a member of the Editorial Board of the Pharmaceutical Patent Analyst (UK) since 2012. He is also a member of Japan Patent Attorneys Association (JPAA), Asian Patent Attorneys Association (APAA), Intellectual Property Association of Japan (IPAJ), The Pharmaceutical Society of Japan(PSJ), Japan Pharmaceutical Association (JPA), American Association for the Advancement of Science (AAAS) and Certified Specialist Association of Intellectual Property Management (GSAIPM). He has lectured extensively on Japanese and international/trilateral IP law/practice at the invitation of the Japan Patent Office, Japanese Ministry of Economy, Trade and Industry (Kansai Bureau of Economy, Trade and Industry) and prestigious universities including Kyoto University (Japan) and KAIST (South Korea). He has contributed a number ofarticles on IP law/practice, particularly biotechnology, pharmaceutical industry and sciences, regenerative medicine etc., that have been published in IP/research journals and publications including the Nikkan Kogyo Shimbun, a Japanese technology oriented newspaper, PharmStage (Japan), Research and Development Leader (Japan), and Pharmaceutical Patent Analyst (UK).

No comments yet.